|
시장보고서
상품코드
2078254
줄기세포 시장 : 종류별, 용도별, 기술별, 지역별Stem Cells Market, by Type, by Application, by Technology and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
줄기세포 시장 규모는 2026년에 167억 8,000만 달러로 추정되며, 2033년까지 312억 7,000만 달러에 달할 것으로 전망됩니다. 2026년부터 2033년까지 CAGR 9.3%로 성장할 것으로 예측됩니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 167억 8,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) | 9.30% | 예측 금액(2033년) | 312억 7,000만 달러 |
줄기세포는 체내의 ‘원료’이며, 특수한 기능을 가진 다른 모든 세포가 생성되는 근원이 되는 세포입니다. 체내나 실험실의 적절한 조건 하에서, 줄기세포는 분열하여 ‘자손세포’라고 불리는 새로운 세포를 형성합니다. 이러한 자손세포들은 새로운 줄기세포가 되거나, 혈액세포, 뇌세포, 심근세포, 골세포 등 보다 특정한 기능을 가진 분화세포가 됩니다. 체내의 그 어떤 세포도 새로운 종류의 세포를 만들어내는 자연적인 능력을 가지고 있지 않습니다. 줄기세포는 앞으로 많은 질병을 치료하기 위한 세포나 조직을 만드는 데 활용될 수도 있습니다. 그 예로는 파킨슨병, 알츠하이머병, 척수 손상, 심장병, 당뇨병, 관절염 등이 있습니다. 줄기세포는 다음 세 가지 점에서 체내의 다른 세포들과 다릅니다.
- 줄기세포는 장기간에 걸쳐 분열하며 스스로를 재생할 수 있습니다.
- 줄기세포는 미분화 상태이므로 체내에서 특정 기능을 수행할 수 없습니다.
- 줄기세포는 근육세포, 혈액세포, 뇌세포 등 분화된 세포로 발달할 가능성이 있습니다.
시장 역학
과학 연구소의 연구원들이 펼치는 연구 개발 활동의 활성화가 전 세계 줄기세포 시장의 성장에 기여하고 있습니다. 예를 들어, 2022년 8월, 이스라엘 레호보트에 위치한 공립 연구 대학인 와이즈만 과학 연구소의 과학자들은 줄기세포만을 사용하여 장기 전구세포를 갖춘, 생존하고 성장하는 생쥐 배아를 생성하는 데 성공했습니다. 그들은 이를 전적으로 자궁 밖에서 실현했으며, 이전에 채취한 배아를 11일령이 될 때까지 유지해 온 인공 자궁의 도움을 받아 배아를 8일간 생존시켰습니다.
본 보고서의 주요 특징
- 본 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 시장의 촉진요인 및 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들이 채택하는 경쟁 전략 등에 관한 중요한 인사이트도 제공하고 있습니다.
- 세계 줄기세포 시장의 주요 기업 개요을 각종 지표(기업 개요, 제품 포트폴리오, 주요 동향, 재무 실적, 전략 등)를 바탕으로 수록하고 있습니다.
- 본 보고서의 인사이트를 바탕으로, 마케팅 담당자와 기업 경영진은 향후 제품 출시, 기술 업데이트, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- '세계 줄기세포 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 재무 분석가 등 이 업계의 다양한 이해관계자들을 대상으로 합니다.
- 이해관계자들은 전 세계 줄기세포 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 할 수 있습니다.
목차
제1장 분석 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 줄기세포 시장 : 종류별(2021-2033년)
제5장 세계의 줄기세포 시장 : 용도별(2021-2033년)
제6장 세계의 줄기세포 시장 : 기술별(2021-2033년)
제7장 세계의 줄기세포 시장 : 지역별(2021-2033년)
제8장 경쟁 구도
제9장 섹션
KSM 26.07.14Stem Cells Market is estimated to be valued at USD 16.78 Bn in 2026 and is expected to reach USD 31.27 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 16.78 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.30% | 2033 Value Projection: | USD 31.27 Bn |
Stem cells are the body's raw materials-cells from which all other cells with specialized functions are generated. Under the right conditions in the body or a laboratory, stem cells divide to form more cells called daughter cells. These daughter cells become either new stem cells or specialized cells (differentiation) with a more specific function, such as blood cells, brain cells, heart muscle cells, or bone cells. No other cell in the body has the natural ability to generate new cell types. Stem cells may one day be used to make cells and tissues for the therapy of many diseases. Examples include Parkinson's disease, Alzheimer's disease, spinal cord injury, heart disease, diabetes, and arthritis. Stem cells are different from other cells in the body in three ways:
- Stem cells can divide and renew itself over a long period of time
- Stem cells are unspecialized, so it cannot do specific functions in the body
- Stem cells have the potential to become specialized cells, such as muscle cells, blood cells, and brain cells
Market Dynamics
Increasing research and development activities conducted by researchers in science institutes are contributing to the growth of the global stem cells market. For instance, in August 2022, scientists from the Weizmann Institute of Science, a public research university in Rehovot, Israel, successfully generated living, growing mouse embryos complete with organ progenitors from stem cells alone-and they did it entirely ex utero, keeping them alive for eight days with the aid of an artificial womb that previously maintained harvested embryos until they were 11 days old.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global stem cells market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Advanced Cell Technology, Inc., Angel Biotechnology Holdings PLC, Biotricity, Lineage Cell Therapeutics, Inc., BrainStorm Cell Limited., CIRM, Celgene Corporation (A subsidiary of Bristol-Myers Squibb Company), Takara Bio Inc., Cellular Engineering Technologies., Cytori Therapeutics Inc., STEMCELL Technologies.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global stem cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global stem cells market.
Detailed Segmentation:
- Global Stem Cells Market, By Type (Revenue, USD Bn, 2021 - 2033)
- Adult Stem Cells
- Human Embryonic Stem Cells
- Induced Pluripotent Stem Cells
- Natural Rosette Cells
- Very Small Embryonic Like Stem Cells
- Global Stem Cells Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Regenerative Medicine
- Drug Discovery and Development
- Global Stem Cells Market, By Technology (Revenue, USD Bn, 2021 - 2033)
- Cell Acquisition
- Cell Production
- Cryopreservation
- Expansion and Sub-Culture
- Global Stem Cells Market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Advanced Cell Technology, Inc.
- Angel Biotechnology Holdings PLC
- Biotricity
- Lineage Cell Therapeutics, Inc.
- BrainStorm Cell Limited.
- CIRM
- Celgene Corporation (A subsidiary of Bristol-Myers Squibb Company)
- Takara Bio Inc.
- Cellular Engineering Technologies.
- Cytori Therapeutics Inc.
- STEMCELL Technologies
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By Technology
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Stem Cells Market, By Type, 2021-2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Adult Stem Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Human Embryonic Stem Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Induced Pluripotent Stem Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Natural Rosette Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Very Small Embryonic Like Stem Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
5. Global Stem Cells Market, By Application, 2021-2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Regenerative Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Drug Discovery and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
6. Global Stem Cells Market, By Technology, 2021-2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Cell Acquisition
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Cell Production
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Cryopreservation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Expansion and Sub-Culture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
7. Global Stem Cells Market, By Region, 2021-2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Region/Country, 2021- 2033, (US$ Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Advanced Cell Technology, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Angel Biotechnology Holdings PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Biotricity
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Lineage Cell Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BrainStorm Cell Limited.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- CIRM
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Celgene Corporation (A subsidiary of Bristol-Myers Squibb Company)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Takara Bio Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cellular Engineering Technologies.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cytori Therapeutics Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- STEMCELL Technologies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
